Skip to content





    This medicine is composed of a component that is from a chain of beta-blockers (β-blockers). Nebix is composed of Nebivolol Hydrochloride which is a cardioselective beta-blocker. This beta-blocker aids in treating high blood pressure, hypertension, and cardiovascular disorders.

    Nebix comes in different levels of dosage. It is available in 2.5mg, 5mg, and 10mg. The level is adjusted by the doctor or physician and it must be followed. The level indicates the amount of Nebivolol Hydrochloride used in the dose.

    nebix back

    The main purpose of using these medicines is to treat cardiac problems, hypertension, and blood pressure. Other minor functions of the medicine include handling heart stroke and renal ailments.

    This medicine is only available in form of film-coated tablets and hence it can be taken orally only. No injection for the medicine is yet available. However, Nebivolol is available in form of injection.

    Side effects of the medicine are not so adverse but may include dizziness, headache, and disturbed heartbeat is reported in some patients.

    Patients having a history of heart stroke greater than a first degree or hepatic impairment are not recommended to use Nebix. Also, females having pregnancy no matter at any month or lactating mothers are prohibited to intake this medicine.

    The leaflet is present within the box of medicine having all information including composition, usage, dosage, indications, and when not to use the medicine instructions. But consult the doctor before taking the medicine.

    Nebix is originally manufactured by Highnoon Laboratories Ltd. All information about the medicine which is instructed on the leaflets are also mentioned on the official website of Highnoon Laboratories.

    In order to purchase any level of dosage of Nebix online, there are several websites such as,,, and many others. It is available at different prices on each website.

    By: Bahaar Abdullah

    Join the conversation

    Your email address will not be published. Required fields are marked *